SUTIMLIMAB-JOME vs TADALAFIL: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
SUTIMLIMAB-JOME vs TADALAFIL: Safety Overview
| Metric | SUTIMLIMAB-JOME | TADALAFIL |
|---|---|---|
| Total FAERS Reports | 209 | 30,683 |
| Deaths Reported | 28 | 3,553 |
| Death Rate | 13.4% | 11.6% |
| Hospitalizations | 37 | 8,717 |
| Average Patient Age | 72.1 yrs | 58.7 yrs |
| % Female Patients | 69.9% | 42.7% |
| FDA Approval Date | N/A | Apr 29, 2019 |
| Manufacturer | N/A | Guangzhou Yixin Cross-border E-commer... |
| Route | N/A | TOPICAL |
| Marketing Status | Prescription | Prescription |